IJRR

International Journal of Research and Review

| Home | Current Issue | Archive | Instructions to Authors | Journals |

Case Report

Year: 2022 | Month: January | Volume: 9 | Issue: 1 | Pages: 231-238

DOI: https://doi.org/10.52403/ijrr.20220129

Clinical Improvement in Patients with Morbus Hansen Borderline Tuberculoid Lesions with 3-Month Multibacillary Regimen Therapy

Putu Eka Ratna Setia Rahayu1, Gusti Ayu Vina Mery Giovani2

1General Practitioner at Siloam Hospital in Badung, Bali, Indonesia, 80361
2Dermatology and Venerology Specialist at Siloam Hospital in Badung, Bali, Indonesia, 80361

Corresponding Author: Putu Eka Ratna Setia Rahayu

ABSTRACT

Background/Aim: Morbus Hansen (MH) is a chronic infectious disease caused by Mycobacterium leprae. The disease has an average incubation period of 3-5 years. Morbus Hansen (MH) has various clinical, microbiological and histopathological features. In the following, a new case of MH is reported with a clinical manifestation of Borderline Tuberculoid (BT) type MH. The patient was treated with the MDT MB regimen for 3 months and had clinical improvement.
Case Report: A 23-year-old boy with complaints of sudden feeling of heat, tingling and cramping from the tip of his right foot to the sole of his right foot. He also complaining about black lesions on both hands, right elbow, face, chest and back. The diagnosis of gout, fungus and dermatitis can be ruled out after microscopic examination of AFB on the right, left ear lobe, and foot lesions showed negative results and histopathological examination results showed Morbus Hansen type BT. The risk factor for contracting Morbus Hansen is the patient has lived in a dormitory for 2.5 years and it is known that there are people who suffer from a similar disease in that environment. The patient was treated using a multibacillary regimen for 3 months and the lesions improved and the numbness decreased. Treatment plan during the case for 12-18 months. This case is unique due to the clinical manifestation has not significant characteristic for MH, AFB is not found from ear lobe smear. MH established after skin biopsy done.
Conclusion: It was reported that one MH case with TB for 3 months had clinical improvement, with plans to continue treatment for 12-18 months.

Keywords: Borderline Tuberculoid; Morbus Hansen, Multibacillary.

[PDF Full Text]